Literature DB >> 10891926

Aura in some patients with familial hemiplegic migraine can be stopped by intranasal ketamine.

H Kaube1, J Herzog, T Käufer, M Dichgans, H C Diener.   

Abstract

Migraine aura is probably caused by cortical-spreading depression. No treatment for acute and severe migraine aura has been described previously. The effect of ketamine (25 mg intranasally) was studied in 11 patients with severe, disabling auras resulting from familial hemiplegic migraine. In five patients ketamine reproducibly reduced the severity and duration of the neurologic deficits, whereas in the remaining six patients no beneficial effect was seen. Ketamine offers, for the first time, a possible treatment option for severe and prolonged aura.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10891926     DOI: 10.1212/wnl.55.1.139

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  45 in total

Review 1.  Sporadic hemiplegic migraine.

Authors:  David F Black
Journal:  Curr Pain Headache Rep       Date:  2004-06

Review 2.  [Facial and eye pain - Neurological differential diagnosis].

Authors:  O Kastrup; H-C Diener; C Gaul
Journal:  Ophthalmologe       Date:  2011-12       Impact factor: 1.059

Review 3.  Ketamine for treatment-resistant unipolar depression: current evidence.

Authors:  Sanjay J Mathew; Asim Shah; Kyle Lapidus; Crystal Clark; Noor Jarun; Britta Ostermeyer; James W Murrough
Journal:  CNS Drugs       Date:  2012-03-01       Impact factor: 5.749

Review 4.  The promise and pitfalls of intranasally administering psychopharmacological agents for the treatment of psychiatric disorders.

Authors:  D S Quintana; A J Guastella; L T Westlye; O A Andreassen
Journal:  Mol Psychiatry       Date:  2015-11-10       Impact factor: 15.992

Review 5.  Migraine with aura: conventional and non-conventional treatments.

Authors:  Giovanni D'Andrea; Davide Colavito; Maurizio Dalle Carbonare; Alberta Leon
Journal:  Neurol Sci       Date:  2011-05       Impact factor: 3.307

Review 6.  Child neurology: Migraine with aura in children.

Authors:  Amy A Gelfand; Heather J Fullerton; Peter J Goadsby
Journal:  Neurology       Date:  2010-08-03       Impact factor: 9.910

Review 7.  Pharmacological targeting of spreading depression in migraine.

Authors:  Katharina Eikermann-Haerter; Anil Can; Cenk Ayata
Journal:  Expert Rev Neurother       Date:  2012-03       Impact factor: 4.618

Review 8.  Single gene disorders causing ischaemic stroke.

Authors:  Saif S M Razvi; Ian Bone
Journal:  J Neurol       Date:  2006-06       Impact factor: 4.849

9.  Effects of ionotropic glutamate receptor antagonists on rat dural artery diameter in an intravital microscopy model.

Authors:  K Y Chan; S Gupta; R de Vries; A H J Danser; C M Villalón; E Muñoz-Islas; A Maassenvandenbrink
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

Review 10.  Visual Snow: a Potential Cortical Hyperexcitability Syndrome.

Authors:  Alaa Bou Ghannam; Victoria S Pelak
Journal:  Curr Treat Options Neurol       Date:  2017-03       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.